X-chromosome gene dosage and the risk of diabetes in Turner syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3289-3296

  Bakalov, Vladimir K ^a   Cheng, Clara ^a   Zhou, Jian ^a   Bondy, Carolyn A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN GLARGINE; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE DOSAGE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; KARYOTYPE; LABORATORY TEST; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONOSOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; TRISOMY; TURNER SYNDROME; X CHROMOSOME;

EID: 69949107901     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0384     Document Type: Article

References (40)

1. Forbes AP, Engel E 1963 The high incidence of diabetes mellitus in 41 patients with gonadal dysgenesis, and their close relatives. Metabolism 12:428-439
2. Wais S, Salvati E 1966 Klinefelter's syndrome and diabetes mellitus. Lancet 2:747-748
3. Burch PR 1969 Klinefelter's syndrome, dizygotic twinning and diabetes mellitus. Nature 221:175-177
4. Bakalov VK, Cooley MM, Troendle J, Bondy CA 2004 The prevalence of diabetes mellitus in the parents of women with Turner's syndrome. Clin Endocrinol (Oxf) 60:272 (Pubitemid 38200912)
5. Gravholt CH, Juul S, Naeraa RW, Hansen J 1998 Morbidity in Turner syndrome. J Clin Epidemiol 51:147-158
6. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS 1998 Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 21:1062-1070
7. Salgin B, Amin R, Yuen K, Williams RM, Murgatroyd P, Dunger DB 2006 Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Horm Res 65:69-75 (Pubitemid 43289471)
8. Elsheikh M, Conway GS 1998 The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf) 49:447-450 (Pubitemid 28475336)
9. Choi IK, Kim DH, Kim HS 2005 The abnormalities of carbohydrate metabolism in Turner syndrome: analysis of risk factors associated with impaired glucose tolerance. Eur J Pediatr 164:442-447
10. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA 2008 Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93:4735-4742
11. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA 2004 Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89:3516-3520 (Pubitemid 38951929)
12. Cohen CD, Lindenmeyer MT, Eichinger F, Hahn A, Seifert M, Moll AG, Schmid H, Kiss E, Gröne E, Gröne HJ, Kretzler M, Werner T, Nelson PJ 2008 Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PLoS ONE 3:e2937
13. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA 2003 DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3
14. Scherf M, Epple A, Werner T 2005 The next generation of literature analysis: integration of genomic analysis into text mining. Brief Bioinform 6:287-297 (Pubitemid 41614550)
15. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410 (Pubitemid 32269192)
16. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
17. Fisher EM, Beer-Romero P, Brown LG, Ridley A, McNeil JA, Lawrence JB, Willard HF, Bieber FR, Page DC 1990 Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell 63:1205-1218 (Pubitemid 120035069)
18. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ 2008 Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest 118:3378-3389
19. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS 2009 Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32:287-294
20. Wooten N, Bakalov VK, Hill S, Bondy CA 2008 Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab 93:2109-2114 (Pubitemid 351831523)
21. Bolar K, Hoffman AR, Maneatis T, Lippe B 2008 Long-term safety of recombinant human growth hormone in Turner syndrome. J Clin Endocrinol Metab 93:344-351 (Pubitemid 351240801)
22. Bondy CA 2007 Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10-25
23. Polychronakos C, Letarte J, Collu R, Ducharme JR 1980 Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 96:1009-1014 (Pubitemid 10068835)
24. AvRuskin TW, Crigler Jr JF, Soeldner JS 1979 Turner's syndrome and carbohydrate metabolism. I. Impaired insulin secretion after tolbutamide and glucagon stimulation tests: evidence of insulin deficiency. Am J Med Sci 277:145-152
25. Rasio E, Antaki A, Van Campenhout J 1976 Diabetes mellitus in gonadal dysgenesis: studies of insulin and growth hormone secretion. Eur J Clin Invest 6:59-66
26. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV 1991 Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 72:832-836 (Pubitemid 21921773)
27. Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS 2005 Adipokine dysregulation in Turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab 90:2948-2953 (Pubitemid 40686348)
28. Winter WE, Nakamura M, House DV 1999 Monogenic diabetes mellitus in youth. The MODY syndromes. Endocrinol Metab Clin North Am 28:765-785
29. Blaschke RJ, Rappold GA 2000 SHOX: growth, Leri-Weill and Turner syndromes. Trends Endocrinol Metab 11:227-230
30. Tartaglia N, Davis S, Hench A, Nimishakavi S, Beauregard R, Reynolds A, Fenton L, Albrecht L, Ross J, Visootsak J, Hansen R, Hagerman R 2008 A new look at XXYY syndrome: medical and psychological features. Am J Med Genet A 146A:1509-1522 (Pubitemid 351792397)
31. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P, Laurberg P, Frystyk J, Flyvbjerg A, Christiansen JS, Gravholt CH 2006 The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29:1591-1598 (Pubitemid 44127586)
32. Carrel L, Willard HF 2005 X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400-404 (Pubitemid 40469185)
33. Elsheikh M, Wass JA, Conway GS 2001 Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clin Endocrinol (Oxf) 55:223-226 (Pubitemid 32868587)
34. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA 1994 Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303 (Pubitemid 24144147)
35. Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS 2007 Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci USA 104:10500-10505 (Pubitemid 47185694)
36. Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, Joly E, Vaillant E, Benmezroua Y, Durand E, Bakaher N, Delannoy V, Vaxillaire M, Cook T, Dallinga-Thie GM, Jansen H, Charles MA, Clément K, Galan P, Hercberg S, Helbecque N, Charpentier G, Prentki M, Hansen T, Pedersen O, Urrutia R, Melloul D, Froguel P 2005 Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic β cell function. Proc Natl Acad Sci USA 102:4807-4812 (Pubitemid 40471535)
37. Senée V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec JC, Charon C, Nicolino M, Boileau P, Cavener DR, Bougnères P, Taha D, Julier C 2006 Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 38:682-687 (Pubitemid 43927311)
38. Zhao L, Guo M, Matsuoka TA, Hagman DK, Parazzoli SD, Poitout V, Stein R 2005 The islet β cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem 280:11887-11894 (Pubitemid 40418503)
39. Mokhtari D, Myers JW, Welsh N 2008 MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH2-terminal kinase and nuclear factor-κB activation in human pancreatic islet cells. Diabetes 57:1896-1904
40. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K 2001 XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891 (Pubitemid 34084979)